Literature DB >> 10909892

Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock.

Z H Meng1, K Dyer, T R Billiar, D J Tweardy.   

Abstract

Production of pro-inflammatory cytokines, such as granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6) occurs at multiple tissue sites in hemorrhagic shock (HS), resulting in elevated circulating plasma levels. The current study was designed to test the hypothesis that circulating G-CSF and IL-6 contribute to polymorphonuclear neutrophilic granulocyte (PMN)-mediated inflammation and organ injury in HS. Sprague-Dawley rats were subjected to decompensated HS (mean arterial blood pressure = 40 mm Hg for 2.5 h), followed by resuscitation with lactated Ringer's solution with or without G-CSF (3 microg/kg) or IL-6 (3 microg/kg). Animals were killed 4 h after resuscitation, and their lungs and livers were assessed quantitatively for PMN infiltration, organ injury, and activation of NF-kappaB and signal transducer and activator or transcription (STAT) 3. Infusion of G-CSF during resuscitation increased PMN infiltration into the lungs by 2.4-fold (P < 0.01) compared with animals resuscitated with lactated Ringer's solution alone. Increased PMN infiltration was accompanied by interstitial edema and pneumocyte swelling, resulting in a 42% increase in lung alveolar wall cross-sectional surface area (P < 0.01) and a 3.7-fold increase in Stat3 activity (P < 0.01). G-CSF infusion did not affect PMN infiltration into the liver and was accompanied by a 68% decrease in focal hepatocellular necrosis (P < 0.01). Infusion of IL-6, in contrast, dramatically decreased inflammation and injury in both the lung and liver; the anti-inflammatory effects of IL-6 may be mediated, in part, by down-modulation of nuclear factor (NF)-kappaB activity. Thus, circulating G-CSF and IL-6 have opposing effects on PMN recruitment and injury in the lung in HS while both protect against hepatic necrosis. The beneficial effect of these cytokines on liver injury in HS appears to be independent of PMN recruitment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909892     DOI: 10.1097/00024382-200014010-00008

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  13 in total

1.  Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.

Authors:  Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Susan G Hilsenbeck; Valeria Poli; David J Tweardy
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

2.  Resuscitation with fresh whole blood ameliorates the inflammatory response after hemorrhagic shock.

Authors:  Amy T Makley; Michael D Goodman; Lou Ann W Friend; Joseph S Deters; Jay A Johannigman; Warren C Dorlac; Alex B Lentsch; Timothy A Pritts
Journal:  J Trauma       Date:  2010-02

3.  A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.

Authors:  Masahiro Shinoda; Arno W Tilles; Naoya Kobayashi; Go Wakabayashi; Atsushi Takayanagi; Toshinori Totsugawa; Hirohisa Harada; Hideaki Obara; Kazuhiro Suganuma; François Berthiaume; Motohide Shimazu; Nobuyoshi Shimizu; Noriaki Tanaka; Masaki Kitajima; Ronald G Tompkins; Mehmet Toner; Martin L Yarmush
Journal:  J Surg Res       Date:  2006-11-01       Impact factor: 2.192

4.  Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection.

Authors:  P Ø Jensen; C Moser; O Kobayashi; H P Hougen; A Kharazmi; N Høiby
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy.

Authors:  Stamatios E Theocharis; Lila J Papadimitriou; Zoi P Retsou; Alexandra P Margeli; Sotirios S Ninos; John D Papadimitriou
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Enhancing or eliminating signals for cell survival to treat disease.

Authors:  David J Tweardy; Naijie Jing
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

Review 7.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Delayed neutralization of interleukin 6 reduces organ injury, selectively suppresses inflammatory mediator, and partially normalizes immune dysfunction following trauma and hemorrhagic shock.

Authors:  Yong Zhang; Jinxiang Zhang; Sebastian Korff; Faez Ayoob; Yoram Vodovotz; Timothy R Billiar
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

9.  Hemostatic properties of a venomic protein in rat organ trauma.

Authors:  Roscoe L Warner; Shannon D McClintock; Adam G Barron; Felix A de la Iglesia
Journal:  Exp Mol Pathol       Date:  2009-09-10       Impact factor: 3.362

Review 10.  The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ.

Authors:  Steven S Welc; Thomas L Clanton
Journal:  Exp Physiol       Date:  2012-08-31       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.